No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
No image published for this recall
Pms-carvedilol 25 mg tablets: out-of-specification (impurity)
Official notice
6 Oct 2026
Last checked
7 Oct 2026
An official Health Canada notice concerns Pms-carvedilol 25 mg tablets: out-of-specification (impurity). The impurity, N-nitroso-carvedilol, may be out of specification in the affected lots. Published 2026-10-06.
What to do now
Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.
Recall number
82725
Official notice
2026-10-06
The hazard
The hazard
The impurity, N-nitroso-carvedilol, may be out of specification in the affected lots.
How to check if you're affected
How to check if you're affected
Compare the product name and identifiers below with the item you own. Follow the official notice if they match.
Other
Recall Numbers
Checked manually this time?
The app alerts you when a new official recall is published — no searching, no checking back.
Turn on recall alertsAffected products
Affected products
Product 1
Risk / hazard
Where it was sold
Where it was sold
The source does not list specific retailers. See the official notice for where affected products were sold.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand
Manufacturer
Phone
Brand: Pharmascience. Contact: the recalling firm if you have any questions about the recall.
Source & status
Source & status
Source
Tier
Category
Classification
App estimate
Recall details
Recall details
Recall number
Classification
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeRelated recalls
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Pms-fluconazole 50 mg tablets; incorrect quantity of tablets
Brand match
Low risk
Markets
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Pms-quetiapine: out of specification
Brand match
Low risk
Markets
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Pms-busulfan 6 mg ml; out of specification (impurities)
Brand match
Low risk
Markets
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Pms-methylphenidate cr 10 mg capsule; exceed the acceptable intake limit for n-nitroso-methylphenidate
Brand match
High risk
Markets
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Pms-sumatriptan: may not contain the correct amount of tablets (empty blister packs)
Brand match
Medium risk
Markets
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Carvedilol 25 mg tablets: out-of-specification (impurity)
Brand match
Medium risk
Markets
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Remifentanil hydrochloride for injection; out of specification (assay & impurity)
Brand match
Medium risk
Markets
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Pms-busulfan 6mg ml: impurity could be out of specification
Brand match
Low risk
Markets
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Pms-fluconazole 50 mg tablets; incorrect quantity of tablets
Brand match
Low risk
Markets
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Pms-quetiapine: out of specification
Brand match
Low risk
Markets
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Pms-busulfan 6 mg ml; out of specification (impurities)
Brand match
Low risk
Markets
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Pms-methylphenidate cr 10 mg capsule; exceed the acceptable intake limit for n-nitroso-methylphenidate
Brand match
High risk
Markets
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Pms-sumatriptan: may not contain the correct amount of tablets (empty blister packs)
Brand match
Medium risk
Markets
No image published for this recall
The official notice did not include a photo. Check the product details and identifiers below.
Carvedilol 25 mg tablets: out-of-specification (impurity)
Brand match
Medium risk
Markets
Weekly recall digest
Get next week's recalls before you need them.
One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.
This recall was published 6 Oct 2026. The next one won't wait for you to search.
RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.
